Tuberculosis Trial, Recruiting NCT06845618 Sponsor: University of Oxford Condition: Tuberculosis
Back to Tuberculosis

Tuberculosis Trial, Recruiting

NCT06845618
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people newly diagnosed with tuberculosis (TB):

  • Adults aged 18 or older
  • People who have been recently confirmed as having a TB infection through a lab test (either a culture test or a nucleic acid amplification test), at any location in the body
  • People who have not yet started any TB treatment
  • People who are able to understand what the study involves and are willing to give their formal consent to participate

For healthy volunteers:

  • Adults aged 18 or older
  • People who a doctor has assessed as being in good health
  • People who are able to understand what the study involves and are willing to give their formal consent to participate

Who may not be able to join:

For people newly diagnosed with TB:

  • People who have received TB treatment, or a specific type of antibiotic called a fluoroquinolone used against TB, in the last 8 weeks
  • People with a known history of cancer
  • People who are pregnant
  • People who require regular blood transfusions due to anaemia (low red blood cells)

For healthy volunteers:

  • People who have had TB infection in the past, including an inactive ("latent") form of TB
  • People who live with, or have had close contact with, someone who has active TB disease
  • People whose chest X-ray shows changes that could suggest TB in the lungs
  • People experiencing symptoms that would normally prompt a doctor to test for TB, such as a cough lasting more than 2 weeks, fever, unexplained weight loss, or night sweats
  • People with another serious medical condition
  • People who are pregnant
  • People with a known history of cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Timothy Seers, Dr, Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University.

Phone: 055 581 135

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 July 2025
Est. completion
30 September 2027

Where this trial is recruiting

🇹🇭 Thailand

Primary endpoints

Mtb-cfDNA trajectories; Percentage of participants completing sampling schedule

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov